Evidence for parent of origin effect in late-onset Alzheimer disease

被引:46
作者
Bassett, SS
Avramopoulos, D
Fallin, D
机构
[1] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
来源
AMERICAN JOURNAL OF MEDICAL GENETICS | 2002年 / 114卷 / 06期
关键词
family history; genetic imprinting; maternal transmission;
D O I
10.1002/ajmg.10648
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Evidence for a parent of origin effect in Alzheimer disease was obtained from a sample of 148 sibships on which affection status of the parents was sought using family history interviews. The parent study recruited families with two or more affected sibs for late onset AD utilizing rigorous diagnostic criteria. In 74 families, there was evidence of an affected parent; 49 maternal and 25 paternal. Genome scan data were analyzed for the sample as a whole and for the maternal and paternal families separately, using Genehunter-ASM. Seven regions with Z(1r) scores greater than or equal to2 were identified, four in maternal families (chr. 10,12,19,20) and three in paternal families (chr. 1,7,13). With the exception of the chromosome 10 finding, analysis by parent of origin greatly increased evidence of linkage in areas showing no linkage in the overall analyses. For example, a chr. 12 region reached a LOD = 2.29 among maternal families whereas the same region showed a LOD = 0.3 when all families were analyzed together. The strongest findings among maternal families (chr. 10 and 12) were followed up with fine mapping that resulted in an increase in maximum LOD scores from 2.7-3.2 on chr.10, and 2.29-2.42 on chr.12. These analyses highlight the importance of parent of origin effects in late-onset AD families and identify several genomic regions that may include genes linked to late-onset AD specific to disease transmission from the mother and require further investigation. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:679 / 686
页数:8
相关论文
共 47 条
  • [11] A COMPARISON OF FAMILIAL AND SPORADIC ALZHEIMERS-DISEASE
    DUARA, R
    LOPEZALBEROLA, RF
    BARKER, WW
    LOEWENSTEIN, DA
    ZATINSKY, M
    EISDORFER, CE
    WEINBERG, GB
    [J]. NEUROLOGY, 1993, 43 (07) : 1377 - 1384
  • [12] Increased risk of dementia in mothers of Alzheimer's disease cases: Evidence for maternal inheritance
    Edland, SD
    Silverman, JM
    Peskind, ER
    Tsuang, D
    Wijsman, E
    Morris, JC
    [J]. NEUROLOGY, 1996, 47 (01) : 254 - 256
  • [13] Ehrenkrantz D, 1999, AM J MED GENET, V88, P378, DOI 10.1002/(SICI)1096-8628(19990820)88:4<378::AID-AJMG15>3.0.CO
  • [14] 2-8
  • [15] Linkage of plasma Aβ42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees
    Ertekin-Taner, N
    Graff-Radford, N
    Younkin, LH
    Eckman, C
    Baker, M
    Adamson, J
    Ronald, J
    Blangero, J
    Hutton, M
    Younkin, SG
    [J]. SCIENCE, 2000, 290 (5500) : 2303 - +
  • [16] Treatment outcome of tacrine therapy depends on apolipoprotein genotype and gender of the subjects with Alzheimer's disease
    Farlow, MR
    Lahiri, DK
    Poirier, J
    Davignon, J
    Schneider, L
    Hui, SL
    [J]. NEUROLOGY, 1998, 50 (03) : 669 - 677
  • [17] Apolipoprotein E genotype and gender influence response to tacrine therapy
    Farlow, MR
    Lahiri, DK
    Poirier, J
    Davignon, J
    Hui, S
    [J]. APOLIPOPROTEIN E GENOTYPING IN ALZHEIMER'S DISEASE, 1996, 802 : 101 - 110
  • [18] Mitochondria and apoptosis
    Green, DR
    Reed, JC
    [J]. SCIENCE, 1998, 281 (5381) : 1309 - 1312
  • [19] HALL JG, 1990, AM J HUM GENET, V46, P857
  • [20] Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study
    Hofman, A
    Ott, A
    Breteler, MMB
    Bots, ML
    Slooter, AJC
    vanHarskamp, F
    vanDuijn, CN
    Van Broeckhoven, C
    Grobbee, DE
    [J]. LANCET, 1997, 349 (9046) : 151 - 154